CSBR vs HMC
Champions Oncology Inc (CSBR) versus HMC (HMC) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
HMC (HMC) common stock.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
HMC does not have a complete income-statement cache yet.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. HMC currently screens at market cap $0.
Not investment advice. Open the CSBR and HMC stock pages for the full models.
Not investment advice.